Nabil specialises in IP and regulatory advice for clients ranging from start-ups to global players, with a particular focus on the life sciences and other technology-rich sectors.

Nabil provides pragmatic, commercially-minded advice with a focus on intellectual property strategy and regulatory compliance.

In addition to advice on the identification, protection, commercialisation and enforcement of IP rights, Nabil supports clients with commercial contracts, due diligence, and regulatory compliance. With experience from working in-house and in private practice, for commercial and public sector clients, as well as in legal and non-legal roles, Nabil brings an outcomes focus to his advice which his clients appreciate.

Prior to training as a solicitor, Nabil worked in early phase pharmaceutical R&D for AstraZeneca and chaired the Physical Organic Chemistry Group of the Royal Society of Chemistry. Nabil has a Ph.D. in Chemistry from Cambridge University and spent a year and a half undertaking post-doctoral research at the University of Groningen on how the crowded environment of a biological cell impacts the chemistry going on inside it, before moving to a commercial-sector role in fine chemicals manufacturing. He is corresponding author on a number of scientific papers in leading international journals.

CV ansehen CV ausblenden

Aktuelle News & Insights

Life Sciences & Healthcare

Taylor Wessing confirms its intention to open in the Republic of Ireland to pursue tech and life science opportunities

9. April 2021

von mehreren Autoren

Klicken Sie hier für Details
Life Sciences & Healthcare

Paul England and Simon Cohen launch new life sciences IP guide

23. März 2021

von Paul England, DPhil und Simon Cohen

Klicken Sie hier für Details
Life Sciences & Healthcare

Advising leading-edge life sciences companies on transformational roll-up and $114m crossover financing

10. März 2021

von Ross McNaughton und Richard Faichney

Klicken Sie hier für Details
Marken & Werbung

We're confused! How the General Court decides when trade marks are (and aren't) confusingly similar

9. März 2021
Briefing

von Louise Popple

Klicken Sie hier für Details

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.